Victoria Yao, APRN
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,315 and has fallen 98.8% since, to $15 in 2025. Among family clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$529
- Lilly USA, LLC$458
- Boehringer Ingelheim$449
- Bayer$366
- Amgen$350
- GSK$331
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 18 | $529 |
| Lilly USA, LLC | 26 | $458 |
| Boehringer Ingelheim | 25 | $449 |
| Bayer | 23 | $366 |
| Amgen(2 entities) | 21 | $350 |
| GSK | 28 | $331 |
| AstraZeneca | 15 | $238 |
| Novo Nordisk | 10 | $206 |
| Kowa Pharmaceuticals America, Inc. | 10 | $161 |
| AbbVie | 4 | $117 |
| Merck | 5 | $93 |
| Sanofi-aventis U.S. LLC | 6 | $80 |
| Pfizer | 3 | $60 |
| Idorsia Pharmaceuticals US Inc | 3 | $55 |
| Novartis | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Abbott | 1 | $18 |
How this compares
$3,664 in reported general payments places this provider in the 90th percentile of 466 family providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 52 | $1,518 |
| Losartan Potassium | 32 | $787 |
| Amlodipine Besylate | 49 | $771 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $720 |
| Omeprazole | 16 | $382 |
| Azithromycin | 26 | $255 |
| Fluticasone Propionate | 20 | $215 |
| Famotidine | 15 | $193 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $152 |
| Levothyroxine Sodium | 25 | $146 |
| Furosemide | 17 | $80 |
| Prednisone | 25 | $34 |
Paid to pharmacies, not to this prescriber.
Other family in Aiea
- Kristina HalloranAiea$12K
- Marianela JacobAiea$3K
- Sarah Lockwood-SepulvedaAiea$3K
- Joey SesonHonolulu$48K
- Kanna DokgoHonolulu$26K
- John MosesHonolulu$24K
- Cecilia GreenWaipahu$21K
- Sherry Sutherland ChoyKahuku$21K
- Natalie KitamuraPearl City$11K
- Leif MarzHonolulu$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.